Patents by Inventor LUIZ EDUARDO MOREIRA BERMUDEZ

LUIZ EDUARDO MOREIRA BERMUDEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
    Patent number: 11116765
    Abstract: Methods of treatment of NTM lung infections using formulations of liposomal ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: September 14, 2021
    Assignee: GRIFOLS, S.A.
    Inventors: Igor Gonda, James Blanchard, David C. Cipolla, Luiz Eduardo Moreira Bermudez
  • LIPOSOMAL ANTI-INFECTIVE FORMULATIONS TO INHIBIT NON-TUBERCULOUS MYCOBACTERIA (NTM) MICROAGGREGATE FORMATION AND ESTABLISHMENT OF NTM BIOFILM
    Publication number: 20210007985
    Abstract: Methods of treatment to prevent NTM microaggregate formation using formulations of liposomal ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Application
    Filed: March 12, 2018
    Publication date: January 14, 2021
    Applicants: ARADIGM CORPORATION, OREGON STATE UNIVERSITY
    Inventors: Igor GONDA, James BLANCHARD, David C. CIPOLLA, Luiz Eduardo Moreira BERMUDEZ
  • LIPOSOMAL CIPROFLOXACIN FORMULATIONS WITH ACTIVITY AGAINST NON-TUBERCULOUS MYCOBACTERIA
    Publication number: 20200323845
    Abstract: Methods of treatment of NTM lung infections using formulations of liposoma ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Application
    Filed: June 26, 2020
    Publication date: October 15, 2020
    Applicant: GRIFOLS, S.A.
    Inventors: Igor Gonda, James Blanchard, David C. Cipolla, Luiz Eduardo Moreira Bermudez
  • LIPOSOMAL CIPROFLOXACIN FORMULATIONS WITH ACTIVITY AGAINST NON-TUBERCULOUS MYCOBACTERIA
    Publication number: 20190328731
    Abstract: Methods of treatment of NTM lung infections using formulations of liposomal ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Application
    Filed: July 9, 2019
    Publication date: October 31, 2019
    Applicants: ARADIGM CORPORATION, OREGON STATE UNIVERSITY
    Inventors: Igor GONDA, James BLANCHARD, David C. CIPOLLA, Luiz Eduardo Moreira BERMUDEZ
  • Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
    Patent number: 10376508
    Abstract: Methods of treatment of NTM lung infections using formulations of liposomal ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: August 13, 2019
    Assignees: ARADIGM CORPORATION, OREGON STATE UNIVERSITY
    Inventors: Igor Gonda, James Blanchard, David C. Cipolla, Luiz Eduardo Moreira Bermudez
  • LIPOSOMAL CIPROFLOXACIN FORMULATIONS WITH ACTIVITY AGAINST NON-TUBERCULOUS MYCOBACTERIA
    Publication number: 20180092912
    Abstract: Methods of treatment of NTM lung infections using formulations of liposomal ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Application
    Filed: November 22, 2017
    Publication date: April 5, 2018
    Applicants: ARADIGM CORPORATION, OREGON STATE UNIVERSITY
    Inventors: Igor GONDA, James BLANCHARD, David C. CIPOLLA, Luiz Eduardo Moreira BERMUDEZ
  • Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
    Patent number: 9532986
    Abstract: Methods of treatment of NTM lung infections using formulations of liposomal ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: January 3, 2017
    Assignees: ARADIGM CORPORATION, OREGON STATE UNIVERSITY
    Inventors: Igor Gonda, James Blanchard, David C. Cipolla, Luiz Eduardo Moreira Bermudez
  • LIPOSOMAL CIPROFLOXACIN FORMULATIONS WITH ACTIVITY AGAINST NON-TUBERCULOUS MYCOBACTERIA
    Publication number: 20150283133
    Abstract: Methods of treatment of NTM lung infections using formulations of liposomal ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
    Type: Application
    Filed: March 31, 2015
    Publication date: October 8, 2015
    Applicants: ARADIGM CORPORATION, OREGON STATE UNIVERSITY
    Inventors: Igor GONDA, James BLANCHARD, David C. CIPOLLA, LUIZ EDUARDO MOREIRA BERMUDEZ